Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada
British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facilit...
Saved in:
| Published in | Harm reduction journal Vol. 15; no. 1; pp. 46 - 8 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
10.09.2018
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver.
Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported.
About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89).
Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. |
|---|---|
| AbstractList | British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver. Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported. About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89). Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver.BACKGROUNDBritish Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver.Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported.METHODSInsite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported.About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89).RESULTSAbout 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89).Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency.CONCLUSIONSAlthough only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. Background British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver. Methods Insite is a facility offering supervised injection services in Vancouver’s Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported. Results About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25–20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79–3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18–0.89). Conclusions Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. Abstract Background British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver. Methods Insite is a facility offering supervised injection services in Vancouver’s Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported. Results About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25–20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79–3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18–0.89). Conclusions Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver. Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported. About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89). Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. Background British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver. Methods Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported. Results About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89). Conclusions Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency. Keywords: Drug checking, Substance use, Injection drug use, Supervised injection facility, Canada |
| ArticleNumber | 46 |
| Audience | Academic |
| Author | Lysyshyn, Mark Karamouzian, Mohammad Forsting, Sara Kerr, Thomas McNeil, Ryan Dohoo, Carolyn |
| Author_xml | – sequence: 1 givenname: Mohammad surname: Karamouzian fullname: Karamouzian, Mohammad – sequence: 2 givenname: Carolyn surname: Dohoo fullname: Dohoo, Carolyn – sequence: 3 givenname: Sara surname: Forsting fullname: Forsting, Sara – sequence: 4 givenname: Ryan surname: McNeil fullname: McNeil, Ryan – sequence: 5 givenname: Thomas surname: Kerr fullname: Kerr, Thomas – sequence: 6 givenname: Mark surname: Lysyshyn fullname: Lysyshyn, Mark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30200991$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktv1DAURiNURB_wA9ggS2y6aIofcexskKpRgUqV2ABb68aPqYeMPdjJSP33ODMtdCqQF7bsc499re-0Ogox2Kp6S_AlIbL9kAnteFNjImtMOa3li-qENELUghNx9GR9XJ3mvMK44Ey-qo4Zphh3HTmpNtdbGCYYfQwoOgTI2TBCuB-QSdMS6Turf_qwRNmmrdcWuZiQHnyB8p7P02Y-ytYgH1ZW70wOtB_8eH-BfkDQcdradIEWEMDA6-qlgyHbNw_zWfX90_W3xZf69uvnm8XVba25bMeaNAAth75hTU-gY7g3sgeMHREOhG4Z4RQkJn3HXcOMNY0D3jvdGKo7Yik7q272XhNhpTbJryHdqwhe7TZiWipIo9eDVUzqlvai7aVtGt1LAA5CGHAGE0qcLK6Pe9dm6tfW6NJ9guFAengS_J1axq1qCSOinQXnD4IUf002j2rts7bDAMHGKStKMGWUcTm_-_0zdBWnFMpXzVRHJO8E-UstoTTgg4vlXj1L1RXnQjCBW1yoy39QZRi79rpkyfmyf1Dw7mmjfzp8zEsBxB7QKeacrFPaj7v0FLMfFMFqTqbaJ1OVZKo5mWr-AvKs8lH-_5rfyeLlaw |
| CitedBy_id | crossref_primary_10_1016_j_drugalcdep_2025_112631 crossref_primary_10_1016_j_drugpo_2020_102769 crossref_primary_10_1093_jat_bkaa181 crossref_primary_10_1016_j_socscimed_2022_115229 crossref_primary_10_1186_s13011_023_00590_7 crossref_primary_10_1097_ADM_0000000000001299 crossref_primary_10_1016_j_drugpo_2022_103741 crossref_primary_10_1136_jech_2018_210599 crossref_primary_10_1016_j_drugpo_2021_103463 crossref_primary_10_1080_09687637_2024_2412995 crossref_primary_10_1186_s12954_020_00414_y crossref_primary_10_1371_journal_pone_0288656 crossref_primary_10_3390_ijerph20115999 crossref_primary_10_1089_can_2019_0104 crossref_primary_10_1161_CIR_0000000000000958 crossref_primary_10_1146_annurev_publhealth_090419_102727 crossref_primary_10_1186_s12954_022_00720_7 crossref_primary_10_1111_add_15323 crossref_primary_10_1111_dar_13004 crossref_primary_10_1186_s12954_020_00365_4 crossref_primary_10_1007_s11606_021_06904_4 crossref_primary_10_1371_journal_pone_0292812 crossref_primary_10_1016_j_drugalcdep_2022_109610 crossref_primary_10_1097_PHH_0000000000002061 crossref_primary_10_1111_dar_13370 crossref_primary_10_1016_j_drugalcdep_2021_108666 crossref_primary_10_1016_j_forc_2023_100475 crossref_primary_10_1038_d41586_019_02689_z crossref_primary_10_1016_j_drugpo_2021_103237 crossref_primary_10_1080_09687637_2019_1645094 crossref_primary_10_1007_s12024_021_00381_1 crossref_primary_10_1371_journal_pmed_1002964 crossref_primary_10_1080_08897077_2021_1946893 crossref_primary_10_7202_1085168ar crossref_primary_10_1002_dta_3022 crossref_primary_10_1097_YCO_0000000000000607 crossref_primary_10_1016_j_saa_2022_121684 crossref_primary_10_1177_1362480619841907 crossref_primary_10_1080_00952990_2020_1771721 crossref_primary_10_1111_dar_13018 crossref_primary_10_1016_j_japh_2023_12_015 crossref_primary_10_2196_24433 crossref_primary_10_1016_j_drugpo_2021_103525 crossref_primary_10_1016_j_drugpo_2023_104015 crossref_primary_10_1080_08897077_2020_1864569 crossref_primary_10_1080_15563650_2019_1657583 crossref_primary_10_17269_s41997_024_00906_5 crossref_primary_10_1016_j_abrep_2019_100212 crossref_primary_10_1186_s12954_020_00454_4 crossref_primary_10_1055_a_2301_7224 crossref_primary_10_1080_16066359_2021_2007888 crossref_primary_10_1016_j_dadr_2022_100074 crossref_primary_10_1186_s12954_024_01048_0 crossref_primary_10_1007_s11524_022_00679_7 crossref_primary_10_1016_j_drugpo_2023_103972 crossref_primary_10_1186_s12954_022_00590_z crossref_primary_10_1002_jrs_6133 crossref_primary_10_1016_j_drugpo_2023_104301 crossref_primary_10_1016_j_drugpo_2020_102665 crossref_primary_10_1111_acem_14624 crossref_primary_10_1186_s12954_023_00764_3 crossref_primary_10_1016_j_drugalcdep_2019_107581 crossref_primary_10_1016_j_drugpo_2020_102845 crossref_primary_10_3390_ijerph20064793 crossref_primary_10_1093_aje_kwab129 crossref_primary_10_1016_j_drugpo_2021_103147 crossref_primary_10_1016_j_drugalcdep_2022_109427 crossref_primary_10_1016_j_drugalcdep_2020_108337 crossref_primary_10_1177_00914509211038352 crossref_primary_10_1186_s12954_025_01178_z crossref_primary_10_1186_s12954_023_00905_8 crossref_primary_10_2217_fvl_2018_0206 crossref_primary_10_1016_j_drugpo_2020_102973 crossref_primary_10_1186_s40814_023_01321_2 crossref_primary_10_1016_j_jsat_2022_108790 crossref_primary_10_1016_j_drugpo_2022_103781 crossref_primary_10_1186_s12954_023_00924_5 crossref_primary_10_1186_s12954_023_00871_1 crossref_primary_10_1186_s12954_024_01004_y crossref_primary_10_1186_s12954_021_00478_4 crossref_primary_10_1016_j_drugalcdep_2022_109375 crossref_primary_10_1186_s12954_023_00856_0 crossref_primary_10_1016_j_drugalcdep_2019_01_035 crossref_primary_10_1016_j_jsat_2022_108849 crossref_primary_10_1093_ofid_ofaa503 crossref_primary_10_1016_j_drugalcdep_2020_108202 crossref_primary_10_1016_j_drugalcdep_2018_12_016 crossref_primary_10_1016_j_drugpo_2022_103773 crossref_primary_10_1016_j_drugpo_2019_01_006 crossref_primary_10_1080_00952990_2019_1708087 crossref_primary_10_1007_s11524_020_00489_9 crossref_primary_10_1016_j_drugpo_2023_104086 crossref_primary_10_1016_j_drugpo_2023_104290 crossref_primary_10_1186_s12954_018_0276_0 crossref_primary_10_1080_08897077_2019_1616245 crossref_primary_10_1016_j_drugpo_2018_10_001 crossref_primary_10_1111_add_15734 crossref_primary_10_1016_j_drugpo_2020_102900 crossref_primary_10_1186_s12954_020_00373_4 crossref_primary_10_1016_j_drugalcdep_2021_109006 crossref_primary_10_1097_JAN_0000000000000557 crossref_primary_10_1016_j_drugpo_2021_103169 crossref_primary_10_1111_dar_13580 crossref_primary_10_1186_s12954_023_00830_w crossref_primary_10_1016_j_addbeh_2020_106529 crossref_primary_10_1186_s12954_022_00659_9 crossref_primary_10_1016_j_josat_2023_209185 crossref_primary_10_1016_j_vibspec_2021_103243 crossref_primary_10_2174_1570159X18666200413142632 crossref_primary_10_1016_j_drugpo_2024_104371 crossref_primary_10_1186_s12889_021_11757_x crossref_primary_10_1186_s12954_021_00514_3 crossref_primary_10_1186_s12954_024_01088_6 crossref_primary_10_1093_aje_kwab233 crossref_primary_10_1111_dar_13908 crossref_primary_10_1016_j_drugalcdep_2020_108381 crossref_primary_10_1111_dar_13909 crossref_primary_10_3390_ijerph191911960 crossref_primary_10_1016_j_toxac_2025_01_094 crossref_primary_10_1080_10826084_2023_2231067 crossref_primary_10_4000_poldev_4007 crossref_primary_10_1016_j_amepre_2023_08_016 crossref_primary_10_1016_S2468_2667_23_00082_8 crossref_primary_10_1016_j_drugalcdep_2020_108265 crossref_primary_10_1016_j_drugpo_2020_102864 crossref_primary_10_1111_dar_13113 crossref_primary_10_1016_j_scitotenv_2024_170934 crossref_primary_10_54097_ehss_v22i_13394 crossref_primary_10_1007_s11469_023_01134_7 |
| Cites_doi | 10.15585/mmwr.mm6537a6 10.1146/annurev-publhealth-031914-122957 10.1016/j.addbeh.2017.03.008 10.1186/1477-7517-8-16 10.3109/09687637.2012.755495 10.1016/j.drugalcdep.2017.10.020 10.1016/j.drugalcdep.2014.11.033 10.1016/S0140-6736(18)30057-6 10.1097/02024458-201504000-00002 10.1007/s11904-017-0363-y 10.1002/dta.2335 10.1046/j.1360-0443.2001.96811397.x 10.1016/S0140-6736(07)60369-9 10.1002/dta.1954 10.1097/02024458-201512000-00004 10.1016/j.jsat.2018.01.005 10.1016/j.drugalcdep.2016.11.033 10.1016/0304-3959(95)00084-6 10.1016/j.neuropharm.2017.10.016 10.1186/s12954-017-0179-5 10.1016/j.drugalcdep.2014.10.012 10.1016/j.drugalcdep.2017.12.026 10.1177/002204260203200219 10.1056/NEJMc052939 10.1016/j.drugpo.2016.08.004 10.1186/s12954-015-0088-4 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2018 |
| Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2018 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PYCSY 7X8 5PM DOA |
| DOI | 10.1186/s12954-018-0252-8 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Environmental Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Social Welfare & Social Work Public Health |
| EISSN | 1477-7517 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_38c62b76b8e44cb8aa5a77dafd0121f8 PMC6131768 A557737060 30200991 10_1186_s12954_018_0252_8 |
| Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | British Columbia Canada British Columbia Canada Vancouver British Columbia Canada North America |
| GeographicLocations_xml | – name: British Columbia – name: Canada – name: British Columbia Canada – name: Vancouver British Columbia Canada – name: North America |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 0R~ 29I 2WC 2XV 53G 5GY 5VS 7X7 7XC 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABIVO ABUWG ACGFO ACGFS ACHQT ACIHN ACUHS ADBBV ADRAZ ADUKV AEAQA AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPY ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PATMY PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PYCSY RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7XB 8FK AZQEC DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c586t-14aa65ab434b1a930bd8ba00f17fa7c63152a801b95f43ded4fa5bfc4d2c91e23 |
| IEDL.DBID | M48 |
| ISSN | 1477-7517 |
| IngestDate | Wed Aug 27 01:22:34 EDT 2025 Thu Aug 21 13:58:28 EDT 2025 Sun Aug 24 04:09:04 EDT 2025 Sat Jul 26 00:18:36 EDT 2025 Tue Jun 17 21:24:54 EDT 2025 Tue Jun 10 20:19:12 EDT 2025 Thu Jan 02 23:02:21 EST 2025 Thu Apr 24 23:11:00 EDT 2025 Tue Jul 01 00:46:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Substance use Canada Injection drug use Supervised injection facility Drug checking |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c586t-14aa65ab434b1a930bd8ba00f17fa7c63152a801b95f43ded4fa5bfc4d2c91e23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2109185971?pq-origsite=%requestingapplication% |
| PMID | 30200991 |
| PQID | 2109185971 |
| PQPubID | 105462 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_38c62b76b8e44cb8aa5a77dafd0121f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131768 proquest_miscellaneous_2102323582 proquest_journals_2109185971 gale_infotracmisc_A557737060 gale_infotracacademiconefile_A557737060 pubmed_primary_30200991 crossref_citationtrail_10_1186_s12954_018_0252_8 crossref_primary_10_1186_s12954_018_0252_8 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-09-10 |
| PublicationDateYYYYMMDD | 2018-09-10 |
| PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Harm reduction journal |
| PublicationTitleAlternate | Harm Reduct J |
| PublicationYear | 2018 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | M Karamouzian (252_CR35) 2018; 391 A Kolodny (252_CR29) 2015; 36 TM Brunt (252_CR22) 2017; 9 JD Jones (252_CR31) 2017; 71 I Hungerbuehler (252_CR21) 2011; 8 JJ Deeks (252_CR36) 2010 N Boyd (252_CR13) 2013; 20 A Schroers (252_CR15) 2002; 32 252_CR34 BC Coroners Service (252_CR9) 2017 S Klar (252_CR2) 2016; 65 JK O’Donnell (252_CR7) 2017 S Sherman (252_CR26) 2018 AR Winstock (252_CR20) 2001; 96 C Sage (252_CR23) 2016 K Hayashi (252_CR28) 2018; 183 S Jafari (252_CR1) 2015; 6 252_CR6 L Harper (252_CR17) 2017; 14 J Suzuki (252_CR4) 2017; 171 A Amlani (252_CR10) 2015; 12 JW Toumbourou (252_CR19) 2007; 369 SR Kenney (252_CR11) 2018; 86 C Potier (252_CR25) 2014; 145 252_CR8 J Latimer (252_CR32) 2016; 37 252_CR30 252_CR33 MM Young (252_CR5) 2015; 6 E Wood (252_CR12) 2006; 354 252_CR24 L Hondebrink (252_CR16) 2015; 147 252_CR27 MC Kennedy (252_CR14) 2017; 14 A Paix (252_CR3) 1995; 63 T Brunt (252_CR18) 2017 |
| References_xml | – ident: 252_CR34 – volume-title: Fentanyl Overdose Reduction Checking Analysis Study (FORECAST) year: 2018 ident: 252_CR26 – volume: 65 start-page: 1015 issue: 37 year: 2016 ident: 252_CR2 publication-title: Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6537a6 – volume: 36 start-page: 559 year: 2015 ident: 252_CR29 publication-title: Annu Rev Public Health doi: 10.1146/annurev-publhealth-031914-122957 – volume: 71 start-page: 104 year: 2017 ident: 252_CR31 publication-title: Addict Behav doi: 10.1016/j.addbeh.2017.03.008 – volume: 8 start-page: 16 year: 2011 ident: 252_CR21 publication-title: Harm Reduct J doi: 10.1186/1477-7517-8-16 – volume: 20 start-page: 234 issue: 3 year: 2013 ident: 252_CR13 publication-title: Drugs Educ Prev Policy doi: 10.3109/09687637.2012.755495 – volume: 183 start-page: 1 year: 2018 ident: 252_CR28 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.10.020 – volume-title: Harm reduction and drug checking; a wrap-around service for festivals. Case Study: Shambhala Music Festival year: 2016 ident: 252_CR23 – volume: 147 start-page: 109 year: 2015 ident: 252_CR16 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2014.11.033 – start-page: 1 volume-title: Statistical algorithms in review manager 5. Statistical Methods Group of The Cochrane Collaboration year: 2010 ident: 252_CR36 – volume: 391 start-page: 201 issue: 10117 year: 2018 ident: 252_CR35 publication-title: Lancet doi: 10.1016/S0140-6736(18)30057-6 – volume: 6 start-page: 4 issue: 1 year: 2015 ident: 252_CR1 publication-title: Can J Addict doi: 10.1097/02024458-201504000-00002 – volume: 14 start-page: 161 issue: 5 year: 2017 ident: 252_CR14 publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-017-0363-y – ident: 252_CR8 – ident: 252_CR30 doi: 10.1002/dta.2335 – volume: 96 start-page: 1139 issue: 8 year: 2001 ident: 252_CR20 publication-title: Addiction doi: 10.1046/j.1360-0443.2001.96811397.x – start-page: 19 volume-title: Fentanyl-detected illicit drug overdose deaths, 2012-2017 year: 2017 ident: 252_CR9 – volume: 369 start-page: 1391 issue: 9570 year: 2007 ident: 252_CR19 publication-title: Lancet doi: 10.1016/S0140-6736(07)60369-9 – volume: 9 start-page: 188 issue: 2 year: 2017 ident: 252_CR22 publication-title: Drug Test Anal doi: 10.1002/dta.1954 – volume: 6 start-page: 13 issue: 3 year: 2015 ident: 252_CR5 publication-title: Can J Addict doi: 10.1097/02024458-201512000-00004 – volume: 86 start-page: 65 year: 2018 ident: 252_CR11 publication-title: J Subst Abus Treat doi: 10.1016/j.jsat.2018.01.005 – volume: 171 start-page: 107 year: 2017 ident: 252_CR4 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2016.11.033 – start-page: 1197 volume-title: MMWR Morb mortal Wkly rep. Vol. 66: Centers for Disease Control and Prevention year: 2017 ident: 252_CR7 – ident: 252_CR27 – volume: 63 start-page: 263 issue: 2 year: 1995 ident: 252_CR3 publication-title: Pain doi: 10.1016/0304-3959(95)00084-6 – ident: 252_CR6 doi: 10.1016/j.neuropharm.2017.10.016 – volume: 14 start-page: 52 issue: 1 year: 2017 ident: 252_CR17 publication-title: Harm Reduct J doi: 10.1186/s12954-017-0179-5 – volume-title: Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges year: 2017 ident: 252_CR18 – volume: 145 start-page: 48 year: 2014 ident: 252_CR25 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2014.10.012 – ident: 252_CR33 doi: 10.1016/j.drugalcdep.2017.12.026 – volume: 32 start-page: 635 issue: 2 year: 2002 ident: 252_CR15 publication-title: J Drug Issues doi: 10.1177/002204260203200219 – ident: 252_CR24 – volume: 354 start-page: 2512 issue: 23 year: 2006 ident: 252_CR12 publication-title: N Engl J Med doi: 10.1056/NEJMc052939 – volume: 37 start-page: 111 year: 2016 ident: 252_CR32 publication-title: Int J Drug Policy doi: 10.1016/j.drugpo.2016.08.004 – volume: 12 start-page: 1 issue: 1 year: 2015 ident: 252_CR10 publication-title: Harm Reduct J doi: 10.1186/s12954-015-0088-4 |
| SSID | ssj0029538 |
| Score | 2.5193448 |
| Snippet | British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with... Background British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated... Abstract Background British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 46 |
| SubjectTerms | Addictions Alcohol Analgesics, Opioid - poisoning Analgesics, Opioid - urine British Columbia Canada Chromatography Clients Confidence intervals Consumption Cross-Sectional Studies Drug checking Drug consumption rooms Drug Contamination - prevention & control Drug dosages Drug evaluation Drug overdose Drug Overdose - prevention & control Drug testing Drug use Drugs Fentanyl Fentanyl - poisoning Fentanyl - urine Harm Reduction Heroin - chemistry Humans Injection Injection drug use Intervention Naloxone - therapeutic use Narcotic Antagonists - therapeutic use Narcotics Needle-Exchange Programs Opioid abuse Opioid-Related Disorders - prevention & control Opioid-Related Disorders - urine Opioids Overdose Prevention Public health Reagent Strips Reduction Regression analysis Regression models Services Statistical analysis Street Drugs - poisoning Substance Abuse, Intravenous - prevention & control Substance Abuse, Intravenous - urine Substance use Supervised injection facility Urine |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yJy_it9WnRBAF2bJtkzTpcZVdFkFPru4t5FPXfbSP19fD_vfOpH3lFUEvXjsTSDIzmZlm5hdC3jTKNsY2PhcQjeSc25CraCFrNaWUDkHGHHYjf_5SX1zyT1fi6uCpL6wJG-GBx407YcrVlZW1VYFzZ5UxwkjpTfSIRhZTmy_4vH0yNaVaDdjxdIdZqvqkL_E6C9JmlYOPhyNg4YUSWP-fR_KBT1rWSx44oPP75N4UOdLTccYPyJ3QPiSrsb2Wfg_raLaBvqX7D9325hHZnM1g3rSL1NCIpeLt7Zr67fCDgsAc_iqn_XhiUIhgqVtji2Q_8vfDBkl98PS6_ZXKtloajcOK2ttj-g10phvAGo5pgjkwj8nl-dnXjxf59MZC7oSqd3nJjamFsZxxW5qGFdYra4oiljIa6WoG_t2AF7ONiJz54Hk0wkbHfeWaMlTsCTlquzY8I5QJ8HPSBogZLFeisNxaJSvmFKRkVRUyUuz3XLsJgBzfwVjrlIioWo9i0iAmjWLSKiPv5yGbEX3jb8wfUJAzIwJnpw-gTnpSJ_0vdcrIO1QDjeYNk3Nm6lKAJSJQlj4VQkqGkEMZWS04wSzdkrxXJD0dC72uEIZVQQ5XZuT1TMaRWOrWhm5IPBDlYgNzRp6OejcviRV4mdXAaLnQyMWal5T2-mcCDYewrYTU8vn_2KQX5G6VbKkBL74iR7vtEF5CbLazr5IZ_gaYhjak priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA86XwQRnV_Vq0QQBVlZ2yRN-iRTNoagT07vW0jSZJte2mt7-7D_3nPa3LsVYa_JSWk438k5vxDyrlK2MraqUwHRSMq59akKFrJWk0vpEGTMYTfyt-_l6Rn_uhTLeODWx7LKrU0cDXXdOjwjPywQwVJB-Jt_Wv9N8dUovF2NT2jcJfcQugylWi6vE64KtDneZOaqPOxzvNSC5Fml4OnBEMx80QjZ_79hvuGZ5lWTN9zQySPyMMaP9Ghi-GNyxzf75MF0-EannqJ9spiabukvvwqm8_Q93Q603Z8nZH28g_imbaCGBiwgb65WtO6GcwpsdHiATvvJjlCIa6lbYeNkP9H3wxqnel_Ty-b3WMzV0GAc1tleHdCfIEntADpyQEfwA_OUnJ0c__hymsaXF1InVLlJc25MKYzljNvcVCyztbImy0Iug5GuZOD1Dfg2W4nAWe1rHoywwfG6cFXuC_aM7DVt418QygR4P2k9RBKWK5FZbq2SBXMKErWi8AnJtjzQLsKS4-sYKz2mJ6rUE9s0sE0j27RKyMfdkvWEyXEb8Wdk7I4Q4bTHgbY711E7NVOuLKwsrfKcO6uMEUbK2oQaIe8CfOQDioVGpYefcyb2LsAWET5LHwkhJUMgooQsZpSgrG4-vRUsHY1Fr69FOyFvd9O4EgvgGt8OIw3EvtjWnJDnkxzutsQyvOKqYLWcSehsz_OZ5vJihBKHYC6HhPPl7b_1itwvRq2pwGsvyN6mG_xriMU29s2ocP8AbBUySw priority: 102 providerName: ProQuest |
| Title | Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30200991 https://www.proquest.com/docview/2109185971 https://www.proquest.com/docview/2102323582 https://pubmed.ncbi.nlm.nih.gov/PMC6131768 https://doaj.org/article/38c62b76b8e44cb8aa5a77dafd0121f8 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_38eKL-O3qukQQBblqP5ImfRDZkz2OhTtEXb23kKTJebq0a7sL7n_vTNstVzzuqdBMStOZ6cwkM78h5FUmTaZNlgccvJGAMeMC6Q1ErToSwiLImMVq5LPz9HTB5hf8Yo_s2lt1H7C-MbTDflKLavnu75_tR1D4D43Cy_R9HeFhFQTFMgALDgq-Tw7BMAlsaHDG-kMFIGoaW0dMiEDwSHSHnDc-YmCmGjT____Z14zWMKHymoU6uUfudq4lnbaycJ_sueIBGbf1t_SHW3pdOfqa7m6U1e-HZDXr0b5p6ammHnPJi-2S5tXmkgJHLe6l07r9pVBwcaldYg1l3dLXmxUO1S6nV8WvJq-roF5bTLndHtHvIFTlBtTliDY4CPoRWZzMvn06DbomDIHlMl0HEdM65dqwhJlIZ0locml0GPpIeC1smoADoMHMmYx7luQuZ15z4y3LY5tFLk4ek4OiLNxTQhMOhlAYB06FYZKHhhkjRZxYCTFbHLsRCXffXNkOoRwbZSxVE6nIVLVsUsAmhWxSckTe9lNWLTzHbcTHyMieEJG1mxtldak6RVWJtGlsRGqkY8waqTXXQuTa54h-5-Ehb1AMFEokvJzVXRkDLBGRtNSUcyESxCQakfGAEvTWDod3gqR2Yq9ixGmVEORFI_KyH8aZmAtXuHLT0IAbjBXOI_Kklbt-SUmIp10ZzBYDiRyseThSXP1sUMXBr4sg9nx2-1s_J3fiRksyMOBjcrCuNu4FuGVrMyH74kJMyOF0Ov86h-vx7Pzzl0mzyTFpFPEfb8A26g |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELaq8gASQlCuLQsYiUNCjZrDjp0HhAq02tLjqYV9M7Zjl5ZVsmx2hfZP8RuZybFthNS3vvqIYs34mxl75jMhrzNpMm2yPODgjQSMGRdIbyBq1ZEQFknGLFYjHx2no1P2dczHa-RvVwuDaZUdJtZAnZcWz8i3Y2SwlOD-Rh-nvwN8NQpvV7snNBq1OHDLPxCyVR_2v4B838Tx3u7J51HQvioQWC7TeRAxrVOuDUuYiXSWhCaXRoehj4TXwqYJWDQNuG0y7lmSu5x5zY23LI9tFjkkOgDIvwWGN8RgT4wvA7wM0KO9OY1kul1FeIkGwboMwLMA4OnZvvqJgP8NwRVL2M_SvGL29u6Te62_SncaBXtA1lyxQe42h320qWHaIMOmyJd-dxOvZ46-pV1DOfv1kEx3V5TitPRUU48J68VyQvPZ4oyC2lg8sKdVg1sU_GhqJ1ioWTXjq8UUuyqX0_Piok4eK6jXFvN6l1v0G2huuYA9uUVrsgX9iJzeiEwek_WiLNxTQhMO1lYYB56LYZKHhhkjRZxYCYFhHLsBCTsZKNvSoONrHBNVh0MyVY3YFIhNodiUHJD3qynThgPkusGfULCrgUjfXTeUszPVooFKpE1jI1IjHWPWSK25FiLXPkeKPQ8feYdqoRBk4OesbmslYIlI16V2OBciQeKjARn2RgI42H53p1iqBadKXW6lAXm16saZmHBXuHJRjwFfG8uoB-RJo4erJSUhXqllMFv0NLS35n5Pcf6zpi4H5zGCAHfz-t96SW6PTo4O1eH-8cEzcieud1AGHsOQrM9nC_cc_MC5eVFvPkp-3PRu_wdAg3Aq |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+a+fentanyl+drug+checking+service+for+clients+of+a+supervised+injection+facility%2C+Vancouver%2C+Canada&rft.jtitle=Harm+reduction+journal&rft.au=Karamouzian%2C+Mohammad&rft.au=Dohoo%2C+Carolyn&rft.au=Forsting%2C+Sara&rft.au=McNeil%2C+Ryan&rft.date=2018-09-10&rft.pub=BioMed+Central+Ltd&rft.issn=1477-7517&rft.eissn=1477-7517&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs12954-018-0252-8&rft.externalDocID=A557737060 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-7517&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-7517&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-7517&client=summon |